Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2

Overview of attention for article published in PLOS ONE, June 2009

Altmetric Badge

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 91 Dimensions

Readers on

mendeley: 81 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

TYROSINE KINASE INHIBITORS FOR USE IN A METHOD OF TREATING CANCER IN ASSOCIATION WITH A…

Grant EP-3122354-B1

European Patent Office

SPECIFIC SIRNA MOLECULES, COMPOSITION AND USE THEREOF FOR THE TREATMENT OF TRIPLE…

Application EP-3936136-A1

European Patent Office

TYROSINE KINASE INHIBITORS FOR USE IN A METHOD OF TREATING CANCER IN ASSOCIATION WITH A…

Application EP-3122354-A1

European Patent Office